Resilient Biotics

About:

Resilient Biotics utilizes big data analytics to design microbiome-based therapeutics and advanced screening methods.

Website: https://www.resilientbiotics.com

Twitter/X: resilientbio

Top Investors: Viking Global Investors, Elanco, Fulcrum Global Capital, Berkeley Catalyst Fund (BCF)

Description:

Resilient Biotics utilizes big data analytics to design microbiome-based therapeutics and advanced screening methods for prevention and treatment of deadly infectious diseases, with an initial focus on combating respiratory diseases in livestock animals. Resilient’s goal is to provide more effective treatment strategies while reducing the livestock industry’s current dependency on antibiotics.

Total Funding Amount:

$7.17M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Raleigh, North Carolina, United States

Founded Date:

2016-01-01

Contact Email:

moreinfo(AT)resilientbiotics.com

Founders:

Chris Belnap, Greg Werner

Number of Employees:

11-50

Last Funding Date:

2021-01-29

IPO Status:

Private

Industries:

© 2025 bioDAO.ai